136 related articles for article (PubMed ID: 37644261)
1. A Four-Gene Panel for the Prediction of Prognosis and Immune Cell Enrichment in Gliomas.
Li Z; Jin Y; Zhang P; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Qiu X; Chen C; Que T; Huang G
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37644261
[TBL] [Abstract][Full Text] [Related]
2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
4. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.
Lu J; Liang K; Zou R; Peng Y; Wang H; Huang R; Zeng Z; Feng Z; Fan Y; Zhang S; Ji Y; Pang X; Wang Y; Zhang H; Wang Z
Aging (Albany NY); 2023 Jun; 15(12):5798-5825. PubMed ID: 37367937
[TBL] [Abstract][Full Text] [Related]
6. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
7. Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma.
Wang Q; Wang Z
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23541. PubMed ID: 37712121
[TBL] [Abstract][Full Text] [Related]
8. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
9. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
10. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
11. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
14. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
15. BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
[TBL] [Abstract][Full Text] [Related]
16.
Jiang W; Zheng F; Yao T; Gong F; Zheng W; Yao N
Ann Transl Med; 2021 Nov; 9(22):1686. PubMed ID: 34988195
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
Dong T; Zhang B; Zhang R; Wang C; Liu X; Wang F; Hao N; Tan K; Chang YZ
Front Oncol; 2022; 12():963096. PubMed ID: 36237302
[TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
19.
Tang M; Sun J; Cai Z
J Thorac Dis; 2023 May; 15(5):2601-2615. PubMed ID: 37324064
[TBL] [Abstract][Full Text] [Related]
20. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.
Tan Z; Zhang Z; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Mei Y; Shen XL
Front Neurol; 2022; 13():964590. PubMed ID: 36388191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]